Skip to main content

Archimedes Tech SPAC Partners II Co.

For the period ended Dec 31, 2025. Filed Mar 4, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 4, 2026

ATII$9.81+36.8%Stored close · as of Oct 21, 2026
See the whole filing, with its images and exhibits

Statement of Changes in Shareholders’ Deficit

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’** DEFICIT**

FOR THE YEAR ENDED DECEMBER 31, 2025 AND

FOR THE PERIOD FROM JUNE 7, 2024 (INCEPTION) THROUGH DECEMBER 31, 2024

Ordinary Shares(1) · Additional Paid-in · Accumulated · Total Shareholders’
SharesAmountCapitalDeficitDeficit
Balance — June 7, 2024 (inception)—$—$—$—$—
Issuance of Ordinary Shares to Sponsor5,750,00057524,425—25,000
Net loss———(78,700)(78,700)
Balance — December 31, 20245,750,00057524,425(78,700)(53,700)
Sale of 840,0000 private placement units840,000848,399,916—8,400,000
Fair value of Public Warrants at issuance——1,725,000—1,725,000
Allocated value of transaction costs to warrants and private placement units——(117,194)—(117,194)
Accretion of ordinary shares subject to possible redemption to redemption value——(10,032,147)(14,612,148)(24,644,295)
Net income———7,986,7387,986,738
Balance — December 31, 20256,590,000$659$—$(6,704,110)$(6,703,451)
(1)As of December 31, 2024, included an aggregate of up to 750,000 ordinary shares that were subject to forfeiture depending on the extent to which the underwriters’ over-allotment option was exercised (see Note 5). On February 12, 2025, the Company consummated its Initial Public Offering and sold 23,000,000 Units, including 3,000,000 Units sold pursuant to the full exercise of the underwriters’ option to purchase additional units to cover the over-allotment; as a result, the 750,000 ordinary shares were no longer subject to forfeiture.
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.